Determination of picamilon concentration in human plasma by liquid chromatography-tandem mass spectrometry
Laboratory analysis · 2010
- What was studied
- Human plasma and healthy volunteers
- Main finding
- Validated an LC-MS/MS assay and applied it to human pharmacokinetics. Plasma detection does not establish brain delivery or cognitive benefit.
Linear analyte range · 1–5,000 ng/mL
Reported findings and study design
Human-plasma analytical LC-MS/MS method; mobile phase methanol/ammonium-acetate/formic acid 55:45:01 as printed; flow 0.65 mL/min.
Population or model Human plasma and healthy volunteers
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Linear analyte range | 1–5,000 ng/mL | |
| Lower quantification limit | 1 ng/mL | |
| Intra/inter-assay precision | Below 13.5% | |
| Accuracy | 99.6–101.6% | |
| Analyte mass transitions | m/z 209 → 78 + 106 | Internal standard: paracetamol 152 → 93 + 110 |
Method-validation accuracy is not a Picamilon treatment-response percentage. Human pharmacokinetic values were not supplied in the abstract.
Source for these results ↗ · Reviewed 2026-10-29
Study limitations and source details
Study limitations
- Full methods and risk of bias have not been appraised.
- These findings do not establish long-term, combination or hazardous-work safety.
- Related reports may share participants; source records are not independent-trial counts.
Source details
Indexed citation and abstract checked through Europe PMC; full paper not reviewed.
Sources checked
Citation
Cui W, Chen X, Zhan Y, Zhang Z, Zhang Y, Zhong D. Determination of picamilon concentration in human plasma by liquid chromatography-tandem mass spectrometry Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 878(15-16). PMID 20359966
Study source ↗ · DOI 10.1016/j.jchromb.2010.03.013 · Bibliography entry · Link to this summary